Skip to content
CancerIndex

Loading the knowledge graph…

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer — knowledge graph · CancerIndex